Response to McKinnell et al’s Original Article “Cost-Benefit Analysis From the Hospital Perspective of Universal Active Screening Followed by Contact Precautions for Methicillin-Resistant <i>Staphylococcus aureus</i> Carriers”

O'Riordan, Mary; Harrington, Patricia; Lellen, Kathleen Mac; Ryan, Máirín; Humphreys, Hilary

doi:10.1017/ice.2015.111

Cited by 4 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our findings of increased costs to the hospital remained robust, regardless of number of body sites tested or MRSA identification method. These results are consistent with the literature, including the excellent references presented by O’Riordan et al, 1 and support the notion that hospital-wide, universal surveillance followed by contact precautions would incur significant costs to a single hospital.…”

supporting

confidence: 92%

“…Overall, we agree with O’Riordan and colleagues 1 in their assessment of the literature to support “generally advocating” for MRSA screening as it relates to “infection and control measures.” In particular, understanding the changing epidemiology of MRSA is not fully possible without screening. Depending on the context, available resources, and comparison group, the available data support a benefit to the overall healthcare system for MRSA screening followed by contact precautions.…”

supporting

confidence: 70%

“…We appreciate the letter from O’Riordan et al 1 in response to our article on the cost benefit of methicillin-resistant Staphylococcus aureus (MRSA) screening followed by contact precautions in the hospital setting. 2 We agree that MRSA screening can have an important role as part of infection and control measures.…”

Section: To the Editormentioning

confidence: 99%

See 2 more Smart Citations

Reply to O’Riordan et al

McKinnell

Bartsch

Lee

et al. 2015

Infect. Control Hosp. Epidemiol.

View full text Add to dashboard Cite

supporting

confidence: 92%

supporting

confidence: 70%

See 1 more Smart Citation

Reply to O’Riordan et al

McKinnell

Bartsch

Lee

et al. 2015

Infect. Control Hosp. Epidemiol.

View full text Add to dashboard Cite

MRSA Prevention

Andersen¹

2019

Prevention and Control of Infections in Hospitals

View full text Add to dashboard Cite

Nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) at a palliative care unit: A prospective single service analysis

et al. 2017

View full text Add to dashboard Cite

BackgroundThe emergence of multidrug-resistant bacterial microorganisms is a particular challenge for the health care systems. Little is known about the occurrence of methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Gram-negative bacteria (MDRGNB) in patients of palliative care units (PCU).AimThe primary aim of this study was to determine the carriage of MRSA among patients of a PCU at a German University Hospital and to assess whether the positive cases would have been detected by a risk-factor-based screening-approach.DesignBetween February 2014 and January 2015 patients from our PCU were tested for MRSA carriage within 48 hours following admission irrespective of pre-existing risk factors. In addition, risk factors for MRSA colonization were assessed. Samples from the nostrils and, if applicable, from pre-existing wounds were analysed by standardized culture-based laboratory techniques for the presence of MRSA and of other bacteria and fungi. Results from swabs taken prior to admission were also recorded if available.Results297 out of 317 patients (93.7%) fulfilled one or more MRSA screening criteria. Swabs from 299 patients were tested. The detection rate was 2.1% for MRSA. All MRSA cases would have been detected by a risk-factor-based screening-approach. Considering the detected cases and the results from swabs taken prior to admission, 4.1% of the patients (n = 13) were diagnosed with MRSA and 4.1% with MDRGNB (n = 13), including two patients with MRSA and MDRGNB (0.6%). The rate of MRSA carriage in PCU patients (4.1%) was elevated compared to the rate seen in the general cohort of patients admitted to our University Hospital (2.7%).ConclusionsPCU patients have an increased risk to carry MRSA compared to other hospitalized patients. Although a risk factor-based screening is likely to detect all MRSA carriers amongst PCU patients, we rather recommend a universal screening to avoid the extra effort to identify the few risk factor-negative patients (<7%). As we did not perform a systematic MDRGNB screening, further studies are needed to determine the true prevalence of MDRGNB amongst PCU patients.

show abstract

Response to McKinnell et al’s Original Article “Cost-Benefit Analysis From the Hospital Perspective of Universal Active Screening Followed by Contact Precautions for Methicillin-Resistant Staphylococcus aureus Carriers”

Abstract: 7. Widmer AE, Dangel M. Alcohol-based handrub: evaluation of technique and microbiological efficacy with international infection control professionals.

Cited by 4 publications

References 9 publications

Reply to O’Riordan et al

Reply to O’Riordan et al

MRSA Prevention

Nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) at a palliative care unit: A prospective single service analysis

Contact Info

Product

Resources

About